Gastrointestinal Hemorrhage Clinical Trial
Official title:
Efficacy of Red Cell Distribution Width as a Predictor of High Risk and Early Mortality in Upper Gastro-intestinal Bleeding
Acute upper-gastrointestinal bleeding (UGIB) is a commonly encountered cause of admission in emergency department (ED). Early risk stratification allows appropriate therapy that may be helpful to advance the patient's morbidity and mortality. Investigators hypothesized that early RDW levels may have an independent, linear relationship with recurrent or massive bleeding in UGIB patients.
This is a retrospective clinical study including the UGI patients in ED. All data will be
collected through the electrical medical records. The major endpoints are the high risk
patients and 30-days mortality which defined cases of including any of one among the death,
re-bleeding, and received the intervention (such as blood transfusion, endoscopic therapy and
operation).
Investigators assessed the relationship between initial RDW level and high risk patients and
30-days mortality. In addition, investigators compare the dicrimination power for predicting
outcomes between the UGIB scoring system and RDW level.
Univariate and multivariate logistic regression testing and a Cox hazard regression model
were used to determine the factors associated with outcome variables. In addition,
investigators constructed receiver operating characteristic curves, and the areas under the
curves and confidence intervals were calculated to compare the discriminatory power for
outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02903017 -
Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage
|
Phase 4 | |
Recruiting |
NCT02514304 -
Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding
|
||
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT01477320 -
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.
|
N/A | |
Not yet recruiting |
NCT01549418 -
The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin
|
Phase 4 | |
Completed |
NCT02105532 -
Transfusion in Gastrointestinal Bleeding
|
Phase 2/Phase 3 | |
Recruiting |
NCT05226221 -
Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
|
||
Active, not recruiting |
NCT02874326 -
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
|
Phase 2 | |
Completed |
NCT02928939 -
Therapeutic Conflicts and Multimorbidity
|
||
Withdrawn |
NCT01215058 -
Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer
|
N/A | |
Completed |
NCT01029626 -
Glasgow-Blatschford Score Validation in Digestive Hemorrhage
|
N/A | |
Completed |
NCT00251979 -
A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer
|
Phase 3 | |
Completed |
NCT02991612 -
Rifaximin in Patients With Gastroesophageal Variceal Bleeding
|
N/A | |
Recruiting |
NCT02964195 -
Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding
|
N/A | |
Completed |
NCT02965209 -
European Novel Motorized Spiral Endoscopy Trial
|
N/A | |
Terminated |
NCT02609100 -
Video Capsule Endoscopy Versus Colonoscopy in Patients With Melena and Negative Upper Endoscopy
|
N/A | |
Completed |
NCT02349490 -
Seraseal for Endoscopic Hemostasis
|
Phase 4 | |
Completed |
NCT01872286 -
Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2
|
N/A | |
Withdrawn |
NCT01005147 -
Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding
|
N/A | |
Completed |
NCT00570973 -
Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy
|
Phase 4 |